Business update - First 9 months of the 2015/2016 financial year Business update - First 9 months of the 2015/2016 financial year Business update - First 9 months of the 2015/2016 financial year
Business update - First 9 months of the 2015/2016 financial year
As well as publishing annual and semi-annual results, Gimv has opted to provide quarterly business updates without publishing full results.
The figures given below cover the period from 1 April 2015 to 31 December 2015. All figures refer to the consolidated figures of Gimv (legal consolidation/non-audited figures).
CEO Koen Dejonckheere, on the past quarter: "The past few months showed an intensive investment activity with a good number of new opportunities, which were often the result of a proactive approach towards selected promising companies within the various investment platforms. In combination with an additional positive trend in the valuation of the existing participations, this resulted in a further growth of the investment portfolio."
Equity value (group's share) at 31 December 2015: EUR 1 010.2 million (EUR 43.66 per share), compared to EUR 1 095.6 million (EUR 43.09 per share) on 30 September 2015.
Balance sheet (as at 31/12/2015)
Balance sheet total: EUR 1 156.4 million
Financial assets / portfolio: EUR 944.6 million
Net cash position: EUR 191.4 million
Total investments (on balance sheet): EUR 54.6 million (EUR 34.5 million in the third quarter). Additional investments via co-investment funds: EUR 26.4 million (EUR 6.4 million in the third quarter). Total investments (on balance sheet & via co-investment funds): EUR 81.0 million (EUR 40.9 million in the third quarter).
The main investments in the third quarter concerned Benedenti, Brakel and Equipe Zorgbedrijven, and a follow-on investment in EcoChem.
Total divestment revenues (on balance sheet): EUR 121.0 million (EUR 17.8 million in the third quarter). Additional proceeds from divestments within the co-investment funds: EUR 73.1 million (EUR 26.5 million in the third quarter). Total divestments (on balance sheet & via co-investment funds): EUR 194.1 million (EUR 44.1 million in the third quarter).
Revenues from divestments (including dividends, interests and management fees generated by these participations): 39,0% above the shareholdings’ book value as at 31 March 2015. On these divestments, a total multiple of 1.2x was realized compared to the original acquisition value.
The main divestments in the first quarter: Essar Ports and Xeikon.